Zella 201: A Biomarker-Guided Phase Ii Study Of Alvocidib Followed By Cytarabine And Mitoxantrone In Mcl-1 Dependent Acute Myeloid Leukemia (Aml): Results Of Newly Diagnosed High-Risk Exploratory Arm
BLOOD（2020）
摘要
Background:
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要